Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Company reports record quarterly revenues of $6.1 million, an increase of 39% over Q1 2015 and 11% over Q4 2015Significant expansion of new Immuno-Oncology (IO) test offering, with expansion into 12...
-
RUTHERFORD, N.J., May 05, 2016 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or “The Company”), a leader in enabling precision medicine for oncology through molecular markers and...
-
CGI is uniquely positioned to deliver comprehensive immune marker and genomic data in oncology for biopharma partners and clinical centers for both solid and blood cancersCGI is also actively...
-
RUTHERFORD, N.J., May 03, 2016 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics,...
-
RUTHERFORD, N.J., March 14, 2016 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), an emerging leader in enabling precision medicine for oncology diagnostics, announced today that Panna...
-
Full-Year 2015 revenues up 77% year-over-year to $18 MillionFourth Quarter revenues up 36% year-over-year to $5.5 MillionClosed 2015 with strong cash balance of $19.5 MillionConference call begins...
-
CGI has launched the next-generation sequencing (NGS) panel with CLIA validation and will perform the test for both clinical care and for trials being performed by biotech and pharmaceutical...
-
RUTHERFORD, N.J., March 03, 2016 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, announced...
-
RUTHERFORD, N.J., Feb. 08, 2016 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or “The Company”), a leader in enabling precision medicine for oncology through molecular markers and...
-
RUTHERFORD, N.J. & LOS ANGELES, Feb. 05, 2016 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "The Company"), a leader in enabling precision medicine for oncology through...